ASS1 and esophageal adenocarcinoma: Once more, Ding et al. did not distinguish between esophageal adenocarcinoma and esophageal squamous cell carcinoma [26], thus limiting the interpretability of their findings regarding the rate of ASS1 loss and its implications for patient survival in patients with esophageal adenocarcinoma.